Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit

by Omid Azimaraghi, Maximilian Hammer, Peter Santer, Katharina Platzbecker, Friederike C Althoff, Maria Patrocinio, Stephanie D Grabitz, Karuna Wongtangman, Sandra Rumyantsev, Xinling Xu, Maximilian S Schaefer, Patrick M Fuller, Balachundhar Subramaniam, Matthias Eikermann
Published 2020-07-01